TBDRP Consumer Reviewer
TBDRP Consumer Reviewer
Wendy Adams has been an advocate for the Lyme and tick-borne disease community since 2012 when she helped to establish the
Prior to becoming an advocate for tick-borne disease patients and research, Wendy spent 20 years in the biotechnology industry, directing business strategy and corporate development for companies working in infectious disease, cancer, and autoimmunity. Based on this experience, she has brought to the Lyme advocacy community a deep understanding of diagnostics, research and development, and the infectious disease space. Currently, in her role as Bay Area Lyme Foundation’s research grant director, Wendy oversees the scientific grant funding operations for the organization. She works with her colleagues at Bay Area Lyme, scientists, clinicians, government officials, donors, and the patient community to define emerging and critical patient and research needs in the field of tick-borne diseases and identifies scientists embarking on innovative research that is grounded in a strong scientific basis. Over the past decade, Bay Area Lyme Foundation has become a leading public not-for-profit sponsor of innovative Lyme disease research in the U.S., providing funding to leading scientists from top institutions to promote research of novel diagnostics and therapeutics. This patient-driven foundation also funds ecological research to understand the expansion of tick habitats and human infection risk, and to increase awareness of these diseases.
Since 2020, Wendy has served as a consumer programmatic reviewer for the Congressionally Directed Medical Research Programs Tick-Borne Disease Research Program (TBDRP). With input from the tick-borne disease patient and medical research communities, the TBDRP funds innovative and impactful research of numerous bacterial, viral, and parasitic tick-borne infections in the areas of disease pathogenesis, prevention, diagnosis, and treatment. The program strives to support research that not only demonstrates
Together with her Bay Area Lyme colleagues and fellow TBDRP programmatic reviewers, Wendy aims to change the trajectory of tick-borne diseases so others do not have to endure the years of misdiagnosis and failed treatments that she initially experienced. She believes that with continued funding support and the formation of research collaborations, novel research concepts offer hope in reaching this goal. On the TBDRP programmatic panel, Wendy advocates for patient needs by ensuring that scientifically meritorious applications also address tick-borne disease concerns that present the greatest burden, and therefore have the utmost impact, on the patient community. Above all, she is humbled at how supportive and proud her family is of the work she does in patient and scientific advocacy. Through Wendy’s work, her daughters have seen
The views, opinions, and/or findings contained in this paper are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision.
Last updated Friday, March 24, 2023